Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 11/25/2025 at 22:35, 9 days 8 hours ago

Onco-Innovations participe aux prix d'innovation de l'Université de l'Alberta

Prix De L'innovation Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Université De L'Alberta
BRIEF

published on 11/25/2025 at 22:35, 9 days 8 hours ago

Onco-Innovations Engages in University of Alberta's Innovation Awards

Cancer Research Innovation Awards Onco-Innovations PNKP Technology University Of Alberta
PRESS RELEASE

published on 11/25/2025 at 22:30, 9 days 8 hours ago

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
Onco-Innovations recognized at University of Alberta's 2025 Innovation Awards for advancing oncology innovation and commercializing PNKP Inhibitor Technology from university research

Innovation Awards Cancer Therapeutics Onco-Innovations University Of Alberta PNKP Inhibitor Technology
BRIEF

published on 11/21/2025 at 01:35, 14 days 5 hours ago

Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership

Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
BRIEF

published on 11/21/2025 at 01:35, 14 days 5 hours ago

Onco-Innovations accélère la production d'inhibiteurs de PNKP grâce à un partenariat avec Dalton.

Traitement Du Cancer Études Cliniques Optimisation De La Production Services Pharmaceutiques Dalton Inhibiteur De PNKP
PRESS RELEASE

published on 11/21/2025 at 01:30, 14 days 5 hours ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production

Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
BRIEF

published on 11/19/2025 at 00:05, 16 days 6 hours ago

Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development

AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics
BRIEF

published on 11/19/2025 at 00:05, 16 days 6 hours ago

Onco-Innovations et Kuano collaborent au développement d'un inhibiteur de PNKP

L'IA Dans La Découverte De Médicaments Onco-Innovations Inhibiteur De PNKP Kuano Analyse Quantique
PRESS RELEASE

published on 11/19/2025 at 00:00, 16 days 6 hours ago

Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
Onco-Innovations partners with Kuano Ltd. to accelerate development of PNKP Inhibitor Technology, leveraging quantum analytics for cancer therapeutics. Details on advanced collaboration

Cancer Therapeutics Onco-Innovations Quantum Analytics Kuano Ltd. PNKP Inhibitor Technology
BRIEF

published on 11/08/2025 at 00:05, 27 days 6 hours ago

Inka Health d'Onco-Innovations améliore l'utilisation des données médicales à l'échelle mondiale

Oncologie Maladies Rares Technologies De La Santé Preuves Issues Du Monde Réel Portabilité Des Données

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 11 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE